CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV NASH-NAFLD
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
EASL 2016     Banner2   IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Fewer liver cancers in HBV patients on long-term entecavir
07-06-2016
Carvedilol delays progression of small esophageal varices
07-04-2016
CORRECTED-Hepatitis C core antigen tests accurately diagnose HCV infection
06-29-2016
No sign Alzheimer's, Parkinson's spread through blood transfusion
06-29-2016
Gilead wins U.S. nod for drug for all types of hepatitis C
06-28-2016
View Complete News Library
 
 
September 9-11
10th Annual ILCA (INTERNATIONAL LIVER CANCER ASSOCIATION) Conference
Vancouver, Canada
October 14-19
ACG 2016 Annual Scientific Meeting and Postgraduate Course
Las Vegas, Nevada
November 11-15
AASLD 2016
Boston, Massachusetts
View all Congresses
 
 
 
 
 
  Line  
  Featured Abstracts          
 
Generic medications for hepatitis C
 
Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice
 
The prevalence of bright liver echo pattern in patients with chronic hepatitis C: correlation with steatosis and fibrosis
 
Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus
 
Behavioral Interventions to Reduce Alcohol Use Among Patients with Hepatitis C: A Systematic Review
 
The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
 
 
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
 
Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors
 
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study
 
Noninvasive Tests for Fibrosis Predict 5-Year Mortality and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
 
Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients
 
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
 
 
A low-cost, user-friendly electroencephalographic recording system for the assessment of hepatic encephalopathy
 
Techniques for Transjugular Intrahepatic Portosystemic Shunt Reduction and Occlusion
 
Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy
 
Patients with Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-stage Liver Disease
 
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in HCV-cirrhosis (ANRS CO12 CirVir)
 
Older Patients With Hepatocellular Carcinoma Have More Advanced Disease, Lower Rates of Treatment, and Lower Survival
 
 
          View All Abstracts  
  Line  
                     
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
 
NASH/NAFLD
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
         
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2016 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.